Short Sellers Run for Cover From Major Biotech Stocks

Health and Healthcare

Published: July 26, 2017 9:35 am

Last Updated: January 12, 2020 9:45 am

The short interest data are out for the most recent settlement date, July 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with big potential upside and big potential downside. The health care sector in general has rallied since Donald Trump won the presidency, but now that his repeal of the ACA looking uncertain, the health care rally is called into question.

As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The July 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.

Amgen Inc. (NASDAQ: AMGN) saw its short interest decrease to 8.37 million shares from the previous level of 8.59 million. Shares closed most recently at $180.89, in a 52-week trading range of $133.64 to $184.21.

Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 3.20 million shares from the previous 3.11 million. The stock recently traded at $282.96, within a 52-week range of $244.28 to $333.65.

Celgene Corp.’s (NASDAQ: CELG) short interest for this settlement date decreased to 10.22 million shares from the previous 10.99 million. Shares were changing hands at $136.44, in a 52-week range of $96.93 to $138.93.

Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest fall to 13.38 million shares from 13.66 million in the previous period. Shares were trading at $73.74, in a 52-week trading range of $63.76 to $82.10.

The number of MannKind Corp. (NASDAQ: MNKD) shares short decreased slightly to 22.74 million. The previous reading was 22.84 million. The stock was last seen at $1.26, in a 52-week range of $0.67 to $5.10.

Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest decreased slightly to 5.63 million shares, compared to the previous level of 5.68 million. Shares were trading at $129.35, in a 52-week range of $96.18 to $145.42.

The Average American Has No Idea How Much Money You Can Make Today ^(Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

¹https://www.fdic.gov/national-rates-and-rate-caps